Global Allergic Rhinitis Drugs Market 2019-2023| Increasing Demand for Over-the-Counter Medicines to Boost Growth| Technavio
LONDON--(BUSINESS WIRE)--Dec 14, 2018--The global allergic rhinitis drugs market is expected to post a CAGR of nearly 4% during the period 2019-2023, according to the latest market research report by .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005449/en/
Technavio has released a new market research report on the global allergic rhinitis drugs market for the period 2019-2023. (Graphic: Business Wire)
A key factor driving the growth of the market is the increasing awareness about allergic rhinitis. The increasing awareness about allergic rhinitis improves patient access to the treatment in the early stages of the disease. It also increases the chances of accurate diagnosis by physicians. Globally, the prevalence of allergic rhinitis has increased due to which there has been an increase in the number of initiatives to increase the awareness about the disease.
This market research report on the also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
In this report, Technavio highlights the increasing demand for over-the-counter medicines as one of the key emerging trends in the global allergic rhinitis drugs market:
Global allergic rhinitis drugs market: Increasing demand for over-the-counter medicines
For treating allergic rhinitis, there has been a rise in the demand for over-the-counter medicines. Patients with mild allergies do not require serious care, and they often self-medicate with over-the-counter drugs. Over-the-counter pills such as that do not require a written prescription from a healthcare professional and can be directly purchased from pharmacies.
“Nasal washes can help remove mucus from the nose in mild allergic rhinitis. Nasal washes are easily available at pharmacies and can be purchased without a prescription. This promotes the use of over-the-counter drugs by individuals. Furthermore, these over-the-counter drugs have increased the practice of self-medication among individuals. Self-medication reduces the pressure of medical services. Therefore, patients are inclined toward over-the-counter drugs,” says a senior analyst at Technavio for research on pharmaceuticals.
Global allergic rhinitis drugs market: Segmentation analysis
This market research report segments the global allergic rhinitis drugs market by products (antihistamines, intranasal corticosteroids, and immunotherapies) and geographical regions (APAC, EMEA, and the Americas).
The antihistamines segment held the largest market share in 2018, accounting for over 45% of the market. This product segment is expected to dominate the global market throughout the forecast period.
The Americas led the market in 2018 with a market share of nearly 44%. This region is expected to dominate the market through 2023, however, there will be a decrease in its market share by over 1%.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181214005449/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: TECHNOLOGY OTHER TECHNOLOGY HEALTH PHARMACEUTICAL RESEARCH OTHER SCIENCE SCIENCE GENERAL HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 12/14/2018 01:16 PM/DISC: 12/14/2018 01:16 PM